翻訳と辞書 |
Ravuconazole : ウィキペディア英語版 | Ravuconazole
Ravuconazole (BMS-207147 and ER-30346) is a potent triazole antifungal, being developed by Bristol-Myers Squibb, that is currently in phase I/II clinical trials.〔National Cancer Institute. Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation. In: ClinicalTrials.gov (). Bethesda (MD): National Library of Medicine (US). 2000- (2010 Feb 18 ). Available from: http://clinicaltrials.gov/ct2/show/NCT00064311?term=ravuconazole&spons_ex=Y&rank=1 NLM Identifier: NCT00064311.〕 The drug has shown to have a similar spectrum of activity to voriconazole, with an increased half-life.〔(The Aspergillus Website ), Pasqualotto AC, Denning DW. Ravuconazole. Date accessed: 2010 Feb 18.〕 However, ravuconazole has limited activity against species of ''Fusarium'', ''Scedosporium'', and ''Zygomycetes''. ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Ravuconazole」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|